V
ABBV icon

ViaWealth’s AbbVie ABBV Stock Holding History

ViaWealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Buy
14,024
+706
+5% +$152K 1.78% 10
2026
Q1 		$2.9M Buy
13,318
+34
+0.3% +$7.54K 1.61% 13
2025
Q4 		$3.04M Sell
13,284
-734
-5% -$167K 1.71% 13
2025
Q3 		$3.25M Buy
14,018
+214
+2% +$43.6K 1.77% 12
2025
Q2 		$2.56M Sell
13,804
-643
-4% -$120K 1.51% 13
2025
Q1 		$3.03M Sell
14,447
-304
-2% -$59.1K 1.87% 11
2024
Q4 		$2.62M Sell
14,751
-48
-0.3% -$8.82K 1.58% 12
2024
Q3 		$2.92M Buy
14,799
+54
+0.4% +$10.1K 1.7% 12
2024
Q2 		$2.53M Buy
14,745
+728
+5% +$121K 1.57% 15
2024
Q1 		$2.55M Buy
14,017
+183
+1% +$31.5K 1.6% 15
2023
Q4 		$2.14M Buy
13,834
+628
+5% +$91.6K 1.47% 16
2023
Q3 		$1.97M Buy
13,206
+1,671
+14% +$245K 1.45% 16
2023
Q2 		$1.55M Buy
11,535
+152
+1% +$22.3K 1.16% 18
2023
Q1 		$1.81M Buy
11,383
+16
+0.1% +$2.45K 1.44% 17
2022
Q4 		$1.84M Buy
+11,367
New +$1.74M 1.51% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ViaWealth's ABBV Position: Q2 2026 in Review

ViaWealth increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $152K and bringing the position to 14,024 shares worth $3.53M. The position accounts for 1.78% of the portfolio, ranked #10.

ViaWealth first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ViaWealth held 14,024 shares of AbbVie worth $3.53M as of Q2 2026.
  • ViaWealth bought 706 AbbVie shares in Q2 2026, an estimated $152K.
  • AbbVie made up 1.78% of ViaWealth's portfolio in Q2 2026, its #10 holding.
  • ViaWealth first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ViaWealth's 13F filing for Q2 2026, filed 11 Aug 2026.